Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

AGC's Regenerative Medicine Partnership Might Change the Case for Investing in AGC (TSE:5201) [Yahoo! Finance]

AGC INC UNSP/ADR (ASGLY) 
Company Research Source: Yahoo! Finance
Celaid Therapeutics Inc. announced that it has entered a collaborative research agreement with AGC Inc. to advance iPS cell-derived hematopoietic stem and progenitor cells, aiming to address manufacturing challenges in cell therapy development. Show less Read more
Impact Snapshot
Event Time:
ASGLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ASGLY alerts
Opt-in for
ASGLY alerts

from News Quantified
Opt-in for
ASGLY alerts

from News Quantified